Walleye Trading’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.66M Buy
29,100
+7,200
+33% +$1.61M 0.01% 981
2025
Q4
$4.67M Buy
21,900
+5,400
+33% +$1.12M 0.01% 1327
2025
Q3
$3.28M Buy
+16,500
New +$3.08M 0.01% 1491
2025
Q1
Sell
-4,500
Closed -$620K 4044
2024
Q4
$620K Buy
4,500
+3,600
+400% +$473K ﹤0.01% 2472
2024
Q3
$134K Buy
+900
New +$122K ﹤0.01% 3211
2024
Q2
Sell
-2,400
Closed -$363K 4250
2024
Q1
$363K Sell
2,400
-400
-14% -$57.1K ﹤0.01% 3030
2023
Q4
$353K Buy
2,800
+1,300
+87% +$130K ﹤0.01% 3374
2023
Q3
$140K Sell
1,500
-2,300
-61% -$215K ﹤0.01% 3810
2023
Q2
$339K Sell
3,800
-4,900
-56% -$426K ﹤0.01% 3074
2023
Q1
$933K Buy
8,700
+1,500
+21% +$172K ﹤0.01% 2259
2022
Q4
$879K Buy
7,200
+4,400
+157% +$511K ﹤0.01% 2320
2022
Q3
$289K Buy
2,800
+100
+4% +$9.48K ﹤0.01% 3392
2022
Q2
$251K Sell
2,700
-4,900
-64% -$462K ﹤0.01% 3518
2022
Q1
$892K Buy
+7,600
New +$880K ﹤0.01% 2334
2021
Q4
Sell
-2,800
Closed -$446K 5322
2021
Q3
$446K Buy
2,800
+800
+40% +$109K ﹤0.01% 3028
2021
Q2
$263K Buy
2,000
+300
+18% +$40K ﹤0.01% 3639
2021
Q1
$219K Sell
1,700
-1,000
-37% -$152K ﹤0.01% 3523
2020
Q4
$450K Buy
+2,700
New +$446K ﹤0.01% 2747

Other funds holding ASND

Walleye Trading's ASND Position: Q3 2025 in Review

Walleye Trading sold out of Ascendis Pharma A/S (ASND) in Q3 2025, closing a stake of 2,605 shares — an estimated $486K sold.

Walleye Trading first reported a position in ASND in Q3 2024 and held it in 3 quarters. The position peaked at $3.12M in Q3 2024. 279 funds tracked by Wall St. Rank hold ASND as of Q3 2025.

  • Walleye Trading reported no remaining Ascendis Pharma A/S position as of Q3 2025 after selling out during the quarter.
  • Walleye Trading sold 2,605 Ascendis Pharma A/S shares in Q3 2025, an estimated $486K.
  • Walleye Trading first reported a position in Ascendis Pharma A/S in Q3 2024 and held it in 3 quarters.
  • Walleye Trading's Ascendis Pharma A/S position peaked at $3.12M in Q3 2024.
  • 279 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2025.

Based on Walleye Trading's 13F filing for Q3 2025, filed 14 Nov 2025.